Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

With Ban On Prescribing Data In Effect In N.H., IMS/SDI Petition Supreme Court

This article was originally published in The Pink Sheet Daily

Executive Summary

IMS and SDI are seeking a Supreme Court review of a N.H. law banning the sale of physician prescribing data.

You may also be interested in...



Supreme Court Pick Sotomayor Lacks Rx Track Record, But Vioxx Case Looms

Those poring over Judge Sonia Sotomayor's rulings can get a sense of her views on civil rights, environmental law, privacy and the Second Amendment right to bear arms. But there seems to be no indication of how President Obama's nominee to the Supreme Court might rule on issues affecting the pharmaceutical industry

Supreme Court Pick Sotomayor Lacks Rx Track Record, But Vioxx Case Looms

Those poring over Judge Sonia Sotomayor's rulings can get a sense of her views on civil rights, environmental law, privacy and the Second Amendment right to bear arms. But there seems to be no indication of how President Obama's nominee to the Supreme Court might rule on issues affecting the pharmaceutical industry

Vermont Restriction On Prescribing Data Is Upheld By Court

A New Hampshire federal court says the state can restrict use of prescribing information to contain drug costs and protect public health.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS069255

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel